The seminar, followed by the celebrating the first joint workshop and the signing of a new Memorandum of Understaning between Korea Research Institute of Bioscience and Biotechnology (KRIBB) and Milner Therapeutics Insitute at University of Cambridge (MTI), which took place on November, 2023 in Cambridge, U.K, focuses on bringing together experts to discuss and to share the progress, advances and opportunities of KRIBB-MTI joint research around gene therapy, genome editing, stem cell research and computational biology in biomedicine. Further discussion based on applying one of the U.K.'s finest digital biotech venture models to Kor-U.K. multilateral cooperation outcomes is arranged as well.